Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02429349 · ClinicalTrials.gov registry record · NA
Preservation of Ovarian Tissue and Chemo-Radiotherapy
A NA study of Endocrine Disorders of Female Reproductive System and Secondary Infertility, sponsored by University of Tennessee.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
- 7
- Study locations
NCT02429349 is a NA study of Endocrine Disorders of Female Reproductive System and Secondary Infertility that has completed, run by University of Tennessee. The registered enrollment target is 2 participants. The trial reports 7 study locations across 1 state.
The verdict
NCT02429349, a NA study of Endocrine Disorders of Female Reproductive System and Secondary Infertility, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to assess the results of ovarian tissue freezing, such as resumption or initiation of menses (menstruation: the discharge of blood and tissue from the uterus that happens about every 4 weeks in females who are not pregnant) and pregnancy, prior to starting chemotherapy or radiation treatment (commonly used for cancer treatment or for other conditions such as multiple sclerosis, psoriasis, rheumatoid arthritis). Females who are about to undergo chemotherapy or radiation therapy for cancer or these other medical conditions may stop having menses and may not be able to produce a biological child. Girls who have not achieved puberty and are exposed to chemotherapy (alkylating agents) or radiation treatment, the risk is up to 22-50%. In contrast, girls older than 10 years, or who have achieved puberty, experience acute ovarian failure in over 50% of the cases. By freezing and preserving ovarian tissue will help prevent these outcomes. In fact, when you are considered cured of your disease, you will have another surgical procedure where your own ovarian tissue will be transplanted back to you. This surgery will increase the possibility of resuming/initiating menses and the chance to have a pregnancy.
Conditions Studied
Interventions
- PROCEDURE surgery
Study Locations (7)
Tennessee
- Methodist/LeBonheur Hospital - Germantown
- LeBonheur Children's Hospital - Memphis
- Regional One Health Ob-Gyn Clinic - Memphis
- Regional One Health, Regional Medical Center, Operating Room - Memphis
- Methodist University Hospital - Memphis
- St. Jude Children's Research Hospital - Memphis
- Baptist Memorial Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-05 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02429349
The ClinicalTrials.gov registry entry for NCT02429349 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Endocrine Disorders of Female Reproductive System appearing as the primary indexed condition, and to 1 intervention - of which surgery is the first listed.
NCT02429349 reports 7 study locations spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT02429349 about?
NCT02429349 is a clinical study titled "Preservation of Ovarian Tissue and Chemo-Radiotherapy". The purpose of this study is to assess the results of ovarian tissue freezing, such as resumption or initiation of menses (menstruation: the discharge of blood and tissue from the uterus that happens about every 4 weeks in females who are not pregnant) and pregnancy, prior to starting chemotherapy o...
What is the current status of trial NCT02429349?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2015-05. Estimated completion is 2020-06-30.
What conditions does trial NCT02429349 study?
This clinical trial studies the following conditions: Endocrine Disorders of Female Reproductive System, Secondary Infertility, Infertility Involuntary.
What interventions are being tested in trial NCT02429349?
The interventions under investigation include: surgery (PROCEDURE).
Who is sponsoring clinical trial NCT02429349?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02429349 being conducted?
This trial has 7 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Endocrine Disorders of Female Reproductive System
All registered trials for this condition
Secondary Infertility
All registered trials for this condition
Tennessee
All trials with a study site in Tennessee
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.